Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in Eur J Heart Fail

Retrieve available abstracts of 403 articles:
HTML format
Text format



Single Articles


    March 2017
  1. D'ELIA E, Iacovoni A, Vaduganathan M, Lorini FL, et al
    Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides.
    Eur J Heart Fail. 2017 Mar 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  2. BIERING-SORENSEN T, Shah SJ, Anand I, Sweitzer N, et al
    Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2017 Mar 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  3. MCDONALD K, O'Hanlon R, Savage HO, Khushaba RN, et al
    Sleep-disordered breathing in chronic heart failure is highly variable when measured remotely using a novel non-contact biomotion sensor.
    Eur J Heart Fail. 2017 Mar 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  4. OLIVIER A, Pitt B, Girerd N, Lamiral Z, et al
    Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial.
    Eur J Heart Fail. 2017 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  5. SHARMA K, Fang JC
    The heart-kidney relationship in heart failure: it's not you, it's me.
    Eur J Heart Fail. 2017 Mar 15. doi: 10.1002.
    PubMed     Text format    


  6. RICKENBACHER P, Kaufmann BA, Maeder MT, Bernheim A, et al
    Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Eur J Heart Fail. 2017 Mar 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  7. DOVANCESCU S, Pellicori P, Mabote T, Torabi A, et al
    The effects of short-term omission of daily medication on the pathophysiology of heart failure.
    Eur J Heart Fail. 2017 Mar 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  8. CLELAND JG, Teerlink JR, Davison BA, Shoaib A, et al
    Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studie
    Eur J Heart Fail. 2017 Mar 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  9. SLIWA K, Mebazaa A, Hilfiker-Kleiner D, Petrie MC, et al
    Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM.
    Eur J Heart Fail. 2017 Mar 8. doi: 10.1002.
    PubMed     Text format     Abstract available



  10. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.
    Eur J Heart Fail. 2017;19:438.
    PubMed     Text format    


  11. DIERCKX R, Inglis SC, Clark RA, Prieto-Merino D, et al
    Telemedicine in heart failure: new insights from the Cochrane meta-analyses.
    Eur J Heart Fail. 2017;19:304-306.
    PubMed     Text format    


  12. PAN A
    The real-world evidence of heart failure co-morbidities.
    Eur J Heart Fail. 2017;19:434.
    PubMed     Text format    


  13. BRISTOW MR
    Genetic variation expressed in the brain may impact heart failure.
    Eur J Heart Fail. 2017;19:324-325.
    PubMed     Text format    


  14. MCDONALD K, Gallagher J
    The practice gap in heart failure-the elephant in the room.
    Eur J Heart Fail. 2017;19:301-303.
    PubMed     Text format    


  15. MAASS AH, DeJongste MJ, van der Meer P
    Neuromodulation for systolic heart failure: more than a placebo effect?
    Eur J Heart Fail. 2017;19:401-403.
    PubMed     Text format    



  16. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2017;19:437.
    PubMed     Text format    


  17. DEMISSEI BG, Postmus D, Cleland JG, O'Connor CM, et al
    Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.
    Eur J Heart Fail. 2017 Mar 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  18. VOORS AA, Ouwerkerk W, Zannad F, van Veldhuisen DJ, et al
    Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure.
    Eur J Heart Fail. 2017 Mar 1. doi: 10.1002.
    PubMed     Text format     Abstract available


    February 2017
  19. EMMENS JE, Ter Maaten JM, Voors AA
    Are circulating relaxin levels related to pulmonary hypertension in patients with heart failure?
    Eur J Heart Fail. 2017 Feb 28. doi: 10.1002.
    PubMed     Text format    


  20. PELLICORI P, Urbinati A, Shah P, MacNamara A, et al
    What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?
    Eur J Heart Fail. 2017 Feb 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  21. PAOLILLO S, Mapelli M, Bonomi A, Corra U, et al
    Prognostic role of beta-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.
    Eur J Heart Fail. 2017 Feb 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  22. VAN SPALL HG, Rahman T, Mytton O, Ramasundarahettige C, et al
    Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis.
    Eur J Heart Fail. 2017 Feb 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  23. LUND LH, Carrero JJ, Farahmand B, Henriksson KM, et al
    Association between enrolment in a heart failure quality registry and subsequent mortality-a nationwide cohort study.
    Eur J Heart Fail. 2017 Feb 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  24. PARASKEVAIDIS IA, Ikonomidis I, Simitsis P, Parissis J, et al
    Multidimensional contractile reserve predicts adverse outcome in patients with severe systolic heart failure: a 4-year follow-up study.
    Eur J Heart Fail. 2017 Feb 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  25. NAYOR M, Larson MG, Wang N, Santhanakrishnan R, et al
    The association of chronic kidney disease and microalbuminuria with heart failure with preserved vs. reduced ejection fraction.
    Eur J Heart Fail. 2017 Feb 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  26. GUSTAFSSON F, Rogers JG
    Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.
    Eur J Heart Fail. 2017 Feb 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  27. SCALI MC, Cortigiani L, Simionuc A, Gregori D, et al
    Exercise-induced B-lines identify worse functional and prognostic stage in heart failure patients with depressed left ventricular ejection fraction.
    Eur J Heart Fail. 2017 Feb 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  28. EMDIN M, Aimo A, Passino C, Vergaro G, et al
    Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly?
    Eur J Heart Fail. 2017 Feb 15. doi: 10.1002.
    PubMed     Text format    


  29. DEVORE AD, McNulty S, Alenezi F, Ersboll M, et al
    Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.
    Eur J Heart Fail. 2017 Feb 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  30. HAMMADAH M, Kalogeropoulos AP, Georgiopoulou VV, Weber M, et al
    High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure.
    Eur J Heart Fail. 2017 Feb 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  31. COWIE MR, Simon M, Klein L, Thokala P, et al
    The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective.
    Eur J Heart Fail. 2017 Feb 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  32. LUND LH, Braunschweig F, Benson L, Stahlberg M, et al
    Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry.
    Eur J Heart Fail. 2017 Feb 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  33. HARJOLA P, Tolonen J, Boyd J, Mattila J, et al
    The role of pre-hospital management in acute heart failure.
    Eur J Heart Fail. 2017;19:287-289.
    PubMed     Text format    


  34. STEWART COATS AJ
    Early abnormalities of cerebral blood flow in mild non-ischaemic heart failure: part of a whole-body response?
    Eur J Heart Fail. 2017;19:269-270.
    PubMed     Text format    


  35. NAAR J, Jaye D, Linde C, Neuzil P, et al
    Spinal cord stimulation in heart failure: effect on disease-associated biomarkers.
    Eur J Heart Fail. 2017;19:283-286.
    PubMed     Text format    


  36. METRA M
    February 2017 at a glance: fibrosis, acute heart failure and neurologic abnormalities.
    Eur J Heart Fail. 2017;19:165-166.
    PubMed     Text format    


  37. AHMAD T, Testani JM
    Haemoconcentration as a treatment goal in heart failure: ready for prime time?
    Eur J Heart Fail. 2017;19:237-240.
    PubMed     Text format    


    January 2017
  38. DEMISSEI BG, Cotter G, Prescott MF, Felker GM, et al
    A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  39. SOKOLSKI M, Zymlinski R, Biegus J, Siwolowski P, et al
    Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  40. PAPADAKI A, Martinez-Gonzalez MA, Alonso-Gomez A, Rekondo J, et al
    Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial.
    Eur J Heart Fail. 2017 Jan 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  41. GRUSON D, Pouleur AC, Makris K, Chrysohoou C, et al
    Systematic vitamin D supplementation and monitoring: improving outcomes in heart failure?
    Eur J Heart Fail. 2017 Jan 24. doi: 10.1002.
    PubMed     Text format    


  42. DE KEULENAER GW, Segers VF, Zannad F, Brutsaert DL, et al
    The future of pleiotropic therapy in heart failure. Lessons from the benefits of exercise training on endothelial function.
    Eur J Heart Fail. 2017 Jan 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  43. TER MAATEN JM, Rao VS, Hanberg JS, Perry Wilson F, et al
    Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure.
    Eur J Heart Fail. 2017 Jan 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  44. GUAZZI M, van Heerebeek L, Paulus WJ
    Phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction: trading therapy for prevention.
    Eur J Heart Fail. 2017 Jan 19. doi: 10.1002.
    PubMed     Text format    


  45. KOMAJDA M
    Liraglutide in heart failure: caution is needed.
    Eur J Heart Fail. 2017;19:78-79.
    PubMed     Text format    


  46. EZEKOWITZ JA, Armstrong PW
    Diabetes and heart failure in the crosshairs: where is the target?
    Eur J Heart Fail. 2017;19:66-68.
    PubMed     Text format    


  47. GWIZDALA A, Rozwadowska N, Kolanowski TJ, Malcher A, et al
    Safety, feasibility and effectiveness of first in-human administration of muscle-derived stem/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure.
    Eur J Heart Fail. 2017;19:148-157.
    PubMed     Text format     Abstract available


    December 2016
  48. KOUDSTAAL S, Pujades-Rodriguez M, Denaxas S, Gho JM, et al
    Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people.
    Eur J Heart Fail. 2016 Dec 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  49. FARMAKIS D, Triposkiadis F, Lekakis J, Parissis J, et al
    Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management.
    Eur J Heart Fail. 2016 Dec 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  50. MATYAS C, Nemeth BT, Olah A, Torok M, et al
    Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes.
    Eur J Heart Fail. 2016 Dec 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  51. ANGERMANN CE, Kaspar M, Marx A, Kittel-Schneider S, et al
    A functional variant of the neuropeptide S receptor-1 gene modulates clinical outcomes and healthcare utilization in patients with systolic heart failure: results from the Interdisciplinary Network Heart Failure (INH) Study.
    Eur J Heart Fail. 2016 Dec 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  52. BUNDGAARD H, Axelsson A, Hartvig Thomsen J, Sorgaard M, et al
    The-first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial.
    Eur J Heart Fail. 2016 Dec 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  53. SABBAH HN
    Silent disease progression in clinically stable heart failure.
    Eur J Heart Fail. 2016 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  54. SILVESTRE OM, Goncalves A, Nadruz W Jr, Claggett B, et al
    Ferritin levels and risk of heart failure-the Atherosclerosis Risk in Communities Study.
    Eur J Heart Fail. 2016 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  55. CLELAND JG
    Does aspirin detract from the benefits of mineralocorticoid receptor antagonists in patients with heart failure and a reduced left ventricular ejection fraction? Probably!
    Eur J Heart Fail. 2016 Dec 11. doi: 10.1002.
    PubMed     Text format    


  56. BOHM M
    Heart rate: from heart failure to chronic diseases and cancer. Is there a role for supportive care by heart rate reduction?
    Eur J Heart Fail. 2016 Dec 4. doi: 10.1002.
    PubMed     Text format    


  57. VON HAEHLING S, Papp Z, Anker SD
    ESC Heart Failure: a new journal aims to broaden heart failure views.
    Eur J Heart Fail. 2016;18:1415-1419.
    PubMed     Text format    


    November 2016
  58. DUCA F, Zotter-Tufaro C, Kammerlander AA, Panzenbock A, et al
    Cardiac extracellular matrix is associated with adverse outcome in patients with chronic heart failure.
    Eur J Heart Fail. 2016 Nov 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  59. REDDY YN, Borlaug BA
    Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 Nov 21. doi: 10.1002.
    PubMed     Text format    


  60. LIU LC, Hummel YM, van der Meer P, Berger RM, et al
    Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension.
    Eur J Heart Fail. 2016 Nov 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  61. ROSSIGNOL P, Girerd N, Bakris G, Vardeny O, et al
    Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.
    Eur J Heart Fail. 2016 Nov 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  62. CANNON JA, Shen L, Jhund PS, Kristensen SL, et al
    Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2016 Nov 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  63. GORTER TM, Rienstra M, van Veldhuisen DJ
    Right ventricular dysfunction in heart failure with reduced vs. preserved ejection fraction: non-identical twins?
    Eur J Heart Fail. 2016 Nov 17. doi: 10.1002.
    PubMed     Text format    


  64. GHIO S, Guazzi M, Scardovi AB, Klersy C, et al
    Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction.
    Eur J Heart Fail. 2016 Nov 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  65. ERKELENS CD, van der Wal HH, de Jong BM, Elting JW, et al
    Dynamics of cerebral blood flow in patients with mild non-ischaemic heart failure.
    Eur J Heart Fail. 2016 Nov 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  66. PACKER M, Holcomb R, Abraham WT, Anker S, et al
    Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure.
    Eur J Heart Fail. 2016 Nov 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  67. HEGGERMONT WA, Papageorgiou AP, Heymans S, van Bilsen M, et al
    Metabolic support for the heart: complementary therapy for heart failure?
    Eur J Heart Fail. 2016 Nov 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  68. PARISSIS J, Nikolaou M, Mebazaa A
    The Model for End-stage Liver Disease score in acute heart failure: hepatorenal dysfunction hides behind.
    Eur J Heart Fail. 2016 Nov 4. doi: 10.1002.
    PubMed     Text format    


  69. KAJIMOTO K, Takano T
    Role of functional mitral regurgitation in heart failure with preserved ejection fraction: an unrecognized protagonist?: reply.
    Eur J Heart Fail. 2016 Nov 4. doi: 10.1002.
    PubMed     Text format    


  70. TRIPOSKIADIS F, Pieske B, Butler J, Parissis J, et al
    Global left atrial failure in heart failure.
    Eur J Heart Fail. 2016;18:1307-1320.
    PubMed     Text format     Abstract available


  71. JHUND PS
    Geographic variation in heart failure-a matter of celebration or condemnation?
    Eur J Heart Fail. 2016;18:1329-1330.
    PubMed     Text format    


  72. METRA M
    November 2016 at a glance: the left atrium, screening for heart failure, multimodality imaging for cardiac resynchronization therapy.
    Eur J Heart Fail. 2016;18:1305-1306.
    PubMed     Text format    


  73. MEIJERS WC, de Boer RA, Ho JE
    Biomarkers to identify and prevent new-onset heart failure in the community.
    Eur J Heart Fail. 2016;18:1351-1352.
    PubMed     Text format    


  74. YANG H, Negishi K, Wang Y, Nolan M, et al
    Echocardiographic screening for non-ischaemic stage B heart failure in the community.
    Eur J Heart Fail. 2016;18:1331-1339.
    PubMed     Text format     Abstract available


  75. HAUGAA KH, Edvardsen T
    Global longitudinal strain: the best biomarker for predicting prognosis in heart failure?
    Eur J Heart Fail. 2016;18:1340-1341.
    PubMed     Text format    


    October 2016
  76. ARRIGO M, Gayat E, Parenica J, Ishihara S, et al
    Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry.
    Eur J Heart Fail. 2016 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  77. TARGHER G, Dauriz M, Laroche C, Temporelli PL, et al
    In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry.
    Eur J Heart Fail. 2016 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  78. JORSAL A, Kistorp C, Holmager P, Tougaard RS, et al
    Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
    Eur J Heart Fail. 2016 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  79. COIRO S, Girerd N, Rossignol P, Ferreira JP, et al
    Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myoc
    Eur J Heart Fail. 2016 Oct 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  80. DIEZ J
    Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy.
    Eur J Heart Fail. 2016 Oct 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  81. MEIJERS WC, van der Velde AR, Muller Kobold AC, Dijck-Brouwer J, et al
    Variability of biomarkers in patients with chronic heart failure and healthy controls.
    Eur J Heart Fail. 2016 Oct 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  82. KLIP IT, Voors AA, Swinkels DW, Bakker SJ, et al
    Serum ferritin and risk for new-onset heart failure and cardiovascular events in the community.
    Eur J Heart Fail. 2016 Oct 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  83. BREIDTHARDT T, Weidmann ZM, Twerenbold R, Gantenbein C, et al
    Impact of haemoconcentration during acute heart failure therapy on mortality and its relationship with worsening renal function.
    Eur J Heart Fail. 2016 Oct 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  84. GREENE SJ, Fonarow GC, Solomon SD, Subacius HP, et al
    Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.
    Eur J Heart Fail. 2016 Oct 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  85. OBOKATA M, Borlaug BA
    Right ventricular dysfunction and pulmonary hypertension in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 Oct 13. doi: 10.1002.
    PubMed     Text format    


  86. BIEGUS J, Zymlinski R, Sokolski M, Siwolowski P, et al
    Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure.
    Eur J Heart Fail. 2016 Oct 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  87. METRA M
    October 2016 at a glance: treatment of heart failure.
    Eur J Heart Fail. 2016;18:1209-1210.
    PubMed     Text format    


  88. VADUGANATHAN M, Patel RB, Yancy CW
    Stroke prevention in heart failure and sinus rhythm: where do we go from here?
    Eur J Heart Fail. 2016;18:1267-1269.
    PubMed     Text format    


    September 2016
  89. FITCHETT DH, Udell JA, Inzucchi SE
    Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes.
    Eur J Heart Fail. 2016 Sep 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  90. GORTER TM, Hoendermis ES, van Veldhuisen DJ, Voors AA, et al
    Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  91. NIEWINSKI P, Janczak D, Rucinski A, Tubek S, et al
    Carotid body resection for sympathetic modulation in systolic heart failure: results from first-in-man study.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  92. DINI FL, Carluccio E, Simioniuc A, Biagioli P, et al
    Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  93. ADAMO L, Nassif ME, Novak E, LaRue SJ, et al
    Prevalence of lactic acidaemia in patients with advanced heart failure and depressed cardiac output.
    Eur J Heart Fail. 2016 Sep 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  94. MARTINSON M, Bharmi R, Dalal N, Abraham WT, et al
    Pulmonary artery pressure-guided heart failure management: US cost-effectiveness analyses using the results of the CHAMPION clinical trial.
    Eur J Heart Fail. 2016 Sep 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  95. MELENOVSKY V, Petrak J, Mracek T, Benes J, et al
    Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis.
    Eur J Heart Fail. 2016 Sep 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  96. SANTAS E, Nunez E, Nunez J
    Role of functional mitral regurgitation in heart failure with preserved ejection fraction: an unrecognized protagonist?
    Eur J Heart Fail. 2016 Sep 19. doi: 10.1002.
    PubMed     Text format    


  97. ADAMSON PB, Ginn G, Anker SD, Bourge RC, et al
    Remote haemodynamic-guided care for patients with chronic heart failure: a meta-analysis of completed trials.
    Eur J Heart Fail. 2016 Sep 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  98. KITAI T, Grodin JL, Mentz RJ, Hernandez AF, et al
    Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.
    Eur J Heart Fail. 2016 Sep 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  99. IBRAHIM I, Kuan WS, Frampton C, Troughton R, et al
    Superior performance of N-terminal pro brain natriuretic peptide for diagnosis of acute decompensated heart failure in an Asian compared with a Western setting.
    Eur J Heart Fail. 2016 Sep 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  100. ADELBORG K, Horvath-Puho E, Ording A, Pedersen L, et al
    Heart failure and risk of dementia: a Danish nationwide population-based cohort study.
    Eur J Heart Fail. 2016 Sep 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  101. OMERSA D, Farkas J, Erzen I, Lainscak M, et al
    National trends in heart failure hospitalization rates in Slovenia 2004-2012.
    Eur J Heart Fail. 2016 Sep 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  102. SHAHID F, Shantsila E, Lip GY
    Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?
    Eur J Heart Fail. 2016;18:1172-4.
    PubMed     Text format    


  103. HAWKINS NM, Jhund PS, Pozzi A, O'Meara E, et al
    Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment.
    Eur J Heart Fail. 2016;18:1162-71.
    PubMed     Text format     Abstract available


    August 2016
  104. BORIANI G, Da Costa A, Quesada A, Ricci RP, et al
    Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial.
    Eur J Heart Fail. 2016 Aug 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  105. JESSUP M
    The BA-HEF trial in Africa: a welcome addition to heart failure history.
    Eur J Heart Fail. 2016 Aug 10. doi: 10.1002.
    PubMed     Text format    


  106. PACKER M
    Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA.
    Eur J Heart Fail. 2016 Aug 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  107. KAPELIOS CJ, Malliaras K, Nanas JN
    Dosing of loop diuretics in chronic heart failure: it's time for evidence.
    Eur J Heart Fail. 2016 Aug 5. doi: 10.1002.
    PubMed     Text format    


  108. PINTALHAO M, Castro-Chaves P, Vasques-Novoa F, Goncalves F, et al
    Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload.
    Eur J Heart Fail. 2016 Aug 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  109. THUM T
    Novel models and mechanisms of heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016;18:998-9.
    PubMed     Text format    


  110. METRA M
    August 2016 at a glance: the new ESC guidelines, and pathophysiology, epidemiology and prognosis of heart failure.
    Eur J Heart Fail. 2016;18:889-90.
    PubMed     Text format    


    July 2016
  111. YE S, Qian M, Zhao B, Buchsbaum R, et al
    CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm.
    Eur J Heart Fail. 2016 Jul 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  112. BAEZA-TRINIDAD R, Mosquera-Lozano JD, El Bikri L
    Assessment of bendopnoea impact on decompensated heart failure.
    Eur J Heart Fail. 2016 Jul 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  113. DAMMAN K, Solomon SD, Pfeffer MA, Swedberg K, et al
    Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme.
    Eur J Heart Fail. 2016 Jul 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  114. LINDE C, Eriksson MJ, Hage C, Wallen H, et al
    Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants.
    Eur J Heart Fail. 2016 Jul 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  115. DELGADO JF, Bueno H
    Heart failure: health is priceless... but still expensive.
    Eur J Heart Fail. 2016 Jul 4. doi: 10.1002.
    PubMed     Text format    


  116. LUO N, Mentz RJ
    A Gordian knot: disentangling comorbidities in heart failure.
    Eur J Heart Fail. 2016 Jul 4. doi: 10.1002.
    PubMed     Text format    


  117. NUNEZ J, Garcia-Blas S, Comin-Colet J
    Iron deficiency and risk of early readmission following hospitalization for acute heart failure. Reply.
    Eur J Heart Fail. 2016;18:881.
    PubMed     Text format    


  118. MCDONAGH TA
    Ironing out iron deficiency in heart failure.
    Eur J Heart Fail. 2016;18:796-7.
    PubMed     Text format    


    June 2016
  119. SOLOMON SD, Claggett B, McMurray JJ, Hernandez AF, et al
    Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis.
    Eur J Heart Fail. 2016 Jun 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  120. TRIPOSKIADIS F, Giamouzis G, Parissis J, Starling RC, et al
    Reframing the association and significance of co-morbidities in heart failure.
    Eur J Heart Fail. 2016 Jun 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  121. MAGNANI G, Giugliano RP, Ruff CT, Murphy SA, et al
    Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48.
    Eur J Heart Fail. 2016 Jun 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  122. VADUGANATHAN M, Patel RB, Greene SJ, Gheorghiade M, et al
    Targeting the vulnerable phase of heart failure: initiate novel therapies in stable patients prior to hospitalization.
    Eur J Heart Fail. 2016 Jun 23. doi: 10.1002.
    PubMed     Text format    


  123. BAUERSACHS J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, et al
    Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
    Eur J Heart Fail. 2016 Jun 23. doi: 10.1002.
    PubMed     Text format    


  124. BRAUNSCHWEIG F, Linde C, Benson L, Stahlberg M, et al
    New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
    Eur J Heart Fail. 2016 Jun 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  125. ZAMORA E, Lupon J, Enjuanes C, Pascual-Figal D, et al
    No benefit from the obesity paradox for diabetic patients with heart failure.
    Eur J Heart Fail. 2016 Jun 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  126. EMAMI A, von Haehling S
    Iron deficiency and risk of early readmission following hospitalization for acute heart failure.
    Eur J Heart Fail. 2016 Jun 13. doi: 10.1002.
    PubMed     Text format    


  127. RUTTEN FH, Guder G
    The role of beta-blockers in outcomes of patients hospitalized for heart failure and chronic obstructive pulmonary disease.
    Eur J Heart Fail. 2016 Jun 12. doi: 10.1002.
    PubMed     Text format    


  128. VARDENY O, Claggett B, Packer M, Zile MR, et al
    Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.
    Eur J Heart Fail. 2016 Jun 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  129. CHRIST M, Stork S, Dorr M, Heppner HJ, et al
    Heart failure epidemiology 2000-2013: insights from the German Federal Health Monitoring System.
    Eur J Heart Fail. 2016 Jun 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  130. ANKER SD, Schroeder S, Atar D, Bax JJ, et al
    Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].
    Eur J Heart Fail. 2016;18:727.
    PubMed     Text format    


  131. PARISSIS J, Farmakis D, Triposkiadis F
    Heart failure registries: how far can we go?
    Eur J Heart Fail. 2016;18:626-8.
    PubMed     Text format    


  132. CRESPO-LEIRO MG, Anker SD, Maggioni AP, Coats AJ, et al
    European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.
    Eur J Heart Fail. 2016;18:613-25.
    PubMed     Text format     Abstract available


  133. METRA M
    June 2016 at a glance: epidemiology, renal impairment, heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016;18:587.
    PubMed     Text format    


    May 2016
  134. ALTA S, Onat A, Kaya A
    Shared underlying dynamics between heart failure and cancer: autoimmune activation?
    Eur J Heart Fail. 2016 May 30. doi: 10.1002.
    PubMed     Text format    


  135. VIDAN MT, Bueno H
    Trends in heart failure: going in the right direction?
    Eur J Heart Fail. 2016 May 25. doi: 10.1002.
    PubMed     Text format    


  136. RILEY JP, Astin F, Crespo-Leiro MG, Deaton CM, et al
    Heart Failure Association of the European Society of Cardiology heart failure nurse curriculum.
    Eur J Heart Fail. 2016 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  137. FARMAKIS D, Koeck T, Mullen W, Parissis J, et al
    Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates.
    Eur J Heart Fail. 2016 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  138. KAJIMOTO K, Sato N, Takano T
    Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction.
    Eur J Heart Fail. 2016 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  139. KOMAJDA M, Tavazzi L, Swedberg K, Bohm M, et al
    Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT.
    Eur J Heart Fail. 2016 May 22. doi: 10.1002.
    PubMed     Text format     Abstract available



  140. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribut
    Eur J Heart Fail. 2016 May 20. doi: 10.1002.
    PubMed     Text format    


  141. ANTMAN EM, Bax J, Chazal RA, Creager MA, et al
    Updated Clinical Practice Guidelines on Heart Failure: An International Alignment.
    Eur J Heart Fail. 2016 May 20. doi: 10.1002.
    PubMed     Text format    


  142. SLIWA K, Damasceno A, Davison BA, Mayosi BM, et al
    Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF).
    Eur J Heart Fail. 2016 May 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  143. TOKITSU T, Yamamoto E, Hirata Y, Kusaka H, et al
    Clinical significance of pulse pressure in patients with heart failure with preserved left ventricular ejection fraction.
    Eur J Heart Fail. 2016 May 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  144. CANNON JA, Shen L, Jhund PS, Anand IS, et al
    Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
    Eur J Heart Fail. 2016 May 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  145. ZAFRIR B, Salman N, Crespo-Leiro MG, Anker SD, et al
    Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2016 May 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  146. SENNI M, McMurray JJ, Wachter R, McIntyre HF, et al
    Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens.
    Eur J Heart Fail. 2016 May 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  147. BIEGUS J, Hillege HL, Postmus D, Valente MA, et al
    Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
    Eur J Heart Fail. 2016 May 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  148. GOUDA P, Brown P, Rowe BH, McAlister FA, et al
    Insights into the importance of the electrocardiogram in patients with acute heart failure.
    Eur J Heart Fail. 2016 May 5. doi: 10.1002.
    PubMed     Text format     Abstract available


  149. PRIMESSNIG U, Schonleitner P, Holl A, Pfeiffer S, et al
    Novel pathomechanisms of cardiomyocyte dysfunction in a model of heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 May 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  150. BAYES-GENIS A, Barallat J, Lupon J
    Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction?
    Eur J Heart Fail. 2016;18:576.
    PubMed     Text format    


  151. VAN AELST LN, Celutkiene J, Mebazaa A
    Advanced heart failure: look right to prognosticate right!
    Eur J Heart Fail. 2016;18:573-5.
    PubMed     Text format    


  152. CLARK AL
    Tipping the scales toward fitness as a key modifier of the obesity paradox in heart failure.
    Eur J Heart Fail. 2016;18:554-5.
    PubMed     Text format    


  153. PIEPOLI MF, Corra U, Veglia F, Bonomi A, et al
    Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group.
    Eur J Heart Fail. 2016;18:545-53.
    PubMed     Text format     Abstract available


  154. MAGGIONI AP, Piepoli MF
    The European Society of Cardiology Heart Failure Association Annual Congress.
    Eur J Heart Fail. 2016;18:454-5.
    PubMed     Text format    


  155. OZKAN J
    Frank Ruschitzka MD FESC FRCP shares some thoughts on the future direction of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2016;18:453-4.
    PubMed     Text format    


  156. OZKAN J
    Gerasimos Filippatos MD FESC FHFA, outgoing president of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2016;18:452-3.
    PubMed     Text format    



  157. Abstracts of the Heart Failure 2016 Conference, Florence, Italy, 21-24 May 2016.
    Eur J Heart Fail. 2016;18 Suppl 1:8-521.
    PubMed     Text format    


    April 2016
  158. NAGAI T, Nishimura K, Honma T, Higashiyama A, et al
    Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure.
    Eur J Heart Fail. 2016 Apr 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  159. VOORS AA, Anker SD, Cleland JG, Dickstein K, et al
    A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.
    Eur J Heart Fail. 2016 Apr 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  160. MAHFOUD F, Ewen S, Bohm M
    Renal denervation in patients with heart failure with preserved ejection fraction: end of the beginning?
    Eur J Heart Fail. 2016 Apr 27. doi: 10.1002.
    PubMed     Text format    


  161. VADUGANATHAN M, Pallais JC, Fenves AZ, Butler J, et al
    Serum chloride in heart failure: a salty prognosis.
    Eur J Heart Fail. 2016 Apr 27. doi: 10.1002.
    PubMed     Text format    


  162. MAGGIONI AP
    Outcome improvement of patients with heart failure and reduced ejection fraction: has it ended in the new millennium?
    Eur J Heart Fail. 2016 Apr 27. doi: 10.1002.
    PubMed     Text format    


  163. JACKSON CE, Haig C, Welsh P, Dalzell JR, et al
    The incremental prognostic and clinical value of multiple novel biomarkers in heart failure.
    Eur J Heart Fail. 2016 Apr 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  164. DAVISON BA, Metra M, Senger S, Edwards C, et al
    Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    Eur J Heart Fail. 2016 Apr 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  165. FARRE N, Vela E, Cleries M, Bustins M, et al
    Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients.
    Eur J Heart Fail. 2016 Apr 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  166. STASZEWSKY L, Cortesi L, Tettamanti M, Dal Bo GA, et al
    Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
    Eur J Heart Fail. 2016 Apr 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  167. VAN VELDHUISEN DJ, de Boer RA
    Ischaemia in heart failure with preserved ejection fraction; is it important?
    Eur J Heart Fail. 2016 Apr 20. doi: 10.1002.
    PubMed     Text format    


  168. KOMAJDA M, Anker SD, Cowie MR, Filippatos GS, et al
    Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
    Eur J Heart Fail. 2016 Apr 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  169. JHUND PS, Tavazzi L
    Has the 'epidemic' of heart failure been replaced by a tsunami of co-morbidities?
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format    


  170. MONNERET D, Roche F, Bonnefont-Rousselot D
    Plasma endothelin-1 in acute heart failure: pathophysiological and preanalytical considerations.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format    


  171. VIDAN MT, Blaya-Novakova V, Sanchez E, Ortiz J, et al
    Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  172. ANKER SD, Schroeder S, Atar D, Bax JJ, et al
    Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  173. ALFALEH H, Elasfar AA, Ullah A, AlHabib KF, et al
    Worsening heart failure in 'real-world' clinical practice: predictors and prognostic impact.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  174. WESTENBRINK BD, Brugts JJ, McDonagh TA, Filippatos G, et al
    Heart failure specialization in Europe.
    Eur J Heart Fail. 2016 Apr 12. doi: 10.1002.
    PubMed     Text format    


  175. BORIANI G, Berti E, Belotti LM, Biffi M, et al
    Cardiac device therapy in patients with left ventricular dysfunction and heart failure: 'real-world' data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital).
    Eur J Heart Fail. 2016 Apr 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  176. VOLPE M, Battistoni A, Mastromarino V
    Natriuretic peptides and volume handling in heart failure: the paradigm of a new treatment.
    Eur J Heart Fail. 2016;18:442-4.
    PubMed     Text format    


    March 2016
  177. NUNEZ J, Comin-Colet J, Minana G, Nunez E, et al
    Iron deficiency and risk of early readmission following a hospitalization for acute heart failure.
    Eur J Heart Fail. 2016 Mar 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  178. BUTLER J, Gheorghiade M, Metra M
    Moving away from symptoms-based heart failure treatment: misperceptions and real risks for patients with heart failure.
    Eur J Heart Fail. 2016 Mar 17. doi: 10.1002.
    PubMed     Text format    


  179. SHOAIB A, Farag M, Nasir M, John J, et al
    Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1.
    Eur J Heart Fail. 2016 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  180. FREA S, Pidello S, Bovolo V, Iacovino C, et al
    Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure.
    Eur J Heart Fail. 2016 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  181. PATEL HC, Rosen SD, Hayward C, Vassiliou V, et al
    Renal denervation in heart failure with preserved ejection fraction (RDT-PEF): a randomized controlled trial.
    Eur J Heart Fail. 2016 Mar 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  182. BOHM M, Lloyd SM, Ford I, Borer JS, et al
    Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT.
    Eur J Heart Fail. 2016 Mar 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  183. HARJOLA VP, Mebazaa A, Celutkiene J, Bettex D, et al
    Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology.
    Eur J Heart Fail. 2016;18:226-41.
    PubMed     Text format     Abstract available


  184. METRA M
    March 2016 at a glance. Focus on right ventricular failure and acute heart failure.
    Eur J Heart Fail. 2016;18:225.
    PubMed     Text format    


    February 2016
  185. THORVALDSEN T, Benson L, Dahlstrom U, Edner M, et al
    Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  186. VEGTER EL, van der Meer P, de Windt LJ, Pinto YM, et al
    MicroRNAs in heart failure: from biomarker to target for therapy.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  187. PEARSE SG, Cowie MR
    Sleep-disordered breathing in heart failure.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  188. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
    Thirty-year trends in heart failure hospitalization and mortality rates and the prognostic impact of co-morbidity: a Danish nationwide cohort study.
    Eur J Heart Fail. 2016 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  189. TER MAATEN JM, Damman K, Verhaar MC, Paulus WJ, et al
    Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.
    Eur J Heart Fail. 2016 Feb 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  190. CHIN KL, Collier TJ, Pitt B, McMurray JJ, et al
    Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study.
    Eur J Heart Fail. 2016 Feb 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  191. VON HAEHLING S
    Adding insult to injury: heart failure and incident cancer.
    Eur J Heart Fail. 2016 Feb 1. doi: 10.1002.
    PubMed     Text format    



  192. Corrigendum to 'What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative'[Eur J Heart Fail 2016; 18:66-70].
    Eur J Heart Fail. 2016;18:217.
    PubMed     Text format    


  193. GILBERT RE, Ruschitzka F
    Henry Krum, Pioneering Heart Failure Researcher.
    Eur J Heart Fail. 2016;18:125-6.
    PubMed     Text format    


  194. SINAGRA G, Fabris E
    Direct cellular reprogramming: the hopes and the hurdles.
    Eur J Heart Fail. 2016;18:157-9.
    PubMed     Text format    


  195. VERBRUGGE FH
    Decongestion: more than meets the eye!
    Eur J Heart Fail. 2016;18:192-4.
    PubMed     Text format    


  196. METRA M
    February 2016 at a glance. Focus issue on cardiac regeneration, medical treatment and cardiac devices.
    Eur J Heart Fail. 2016;18:127.
    PubMed     Text format    


  197. VADUGANATHAN M, Prasad V
    Cardiovascular risk assessment in oncological clinical trials: is there a role for centralized events adjudication?
    Eur J Heart Fail. 2016;18:128-32.
    PubMed     Text format    


  198. STOLFO D, Tonet E, Merlo M, Barbati G, et al
    Early right ventricular response to cardiac resynchronization therapy: impact on clinical outcomes.
    Eur J Heart Fail. 2016;18:205-13.
    PubMed     Text format     Abstract available


  199. BATTY JA, Lima JA Jr, Kunadian V
    Direct cellular reprogramming for cardiac repair and regeneration.
    Eur J Heart Fail. 2016;18:145-56.
    PubMed     Text format     Abstract available


  200. SCHUSSLER-LENZ M, Beuneu C, Menezes-Ferreira M, Jekerle V, et al
    Cell-based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints.
    Eur J Heart Fail. 2016;18:133-41.
    PubMed     Text format     Abstract available


  201. VADUGANATHAN M, Goldsmith SR, Senni M, Butler J, et al
    Contrasting acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trial.
    Eur J Heart Fail. 2016;18:185-91.
    PubMed     Text format     Abstract available


    January 2016
  202. PARISSIS J, Farmakis D, Kadoglou N, Ikonomidis I, et al
    Body mass index in acute heart failure: association with clinical profile, therapeutic management and in-hospital outcome.
    Eur J Heart Fail. 2016 Jan 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  203. STARLING RC
    Augmenting outcomes in advanced heart failure: a lot to learn.
    Eur J Heart Fail. 2016 Jan 28. doi: 10.1002.
    PubMed     Text format    


  204. JANKOWSKA EA, Tkaczyszyn M, Suchocki T, Drozd M, et al
    Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.
    Eur J Heart Fail. 2016 Jan 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  205. WONG YW, Mentz RJ, Felker GM, Ezekowitz J, et al
    Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials.
    Eur J Heart Fail. 2016 Jan 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  206. KLERSY C, Boriani G, De Silvestri A, Mairesse GH, et al
    Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta-analysis of randomized, controlled trials in patients with heart failure.
    Eur J Heart Fail. 2016 Jan 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  207. MCKIE PM, Schirger JA, Benike SL, Harstad LK, et al
    Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure.
    Eur J Heart Fail. 2016 Jan 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  208. DIAS A, Franco E
    A position statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology: What about racial differences?
    Eur J Heart Fail. 2016 Jan 21. doi: 10.1002.
    PubMed     Text format    


  209. TERZIC A, Behfar A, Filippatos G
    Clinical development plan for regenerative therapy in heart failure.
    Eur J Heart Fail. 2016 Jan 21. doi: 10.1002.
    PubMed     Text format    


  210. GROTE BEVERBORG N, van der Wal HH, Klip IT, Voors AA, et al
    High serum erythropoietin levels are related to heart failure development in subjects from the general population with albuminuria: data from PREVEND.
    Eur J Heart Fail. 2016 Jan 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  211. TEKTONIDIS TG, Akesson A, Gigante B, Wolk A, et al
    Adherence to a Mediterranean diet is associated with reduced risk of heart failure in men.
    Eur J Heart Fail. 2016 Jan 18. doi: 10.1002.
    PubMed     Text format     Abstract available


  212. TESTANI JM, Hanberg JS, Arroyo JP, Brisco MA, et al
    Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure.
    Eur J Heart Fail. 2016 Jan 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  213. MAGGIONI AP, Orso F, Calabria S, Rossi E, et al
    The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database.
    Eur J Heart Fail. 2016 Jan 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  214. BANKE A, Schou M, Videbaek L, Moller JE, et al
    Incidence of cancer in patients with chronic heart failure: a long-term follow-up study.
    Eur J Heart Fail. 2016 Jan 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  215. SUEMATSU Y, Miura SI, Goto M, Matsuo Y, et al
    LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice.
    Eur J Heart Fail. 2016 Jan 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  216. RUIZ-ESPARZA GU, Segura-Ibarra V, Cordero-Reyes AM, Youker KA, et al
    A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeutics.
    Eur J Heart Fail. 2016 Jan 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  217. VAN RIET EE, Hoes AW, Wagenaar KP, Limburg A, et al
    Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  218. COIRO S, Chouihed T, Girerd N
    Lung ultrasound - The extension of clinical examination in patients with acute heart failure: Reply.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format    


  219. KAMPERIDIS V, Delgado V, van Mieghem NM, Kappetein AP, et al
    Diagnosis and management of aortic valve stenosis in patients with heart failure.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  220. GOLIASCH G, Pavo N, Zotter-Tufaro C, Kammerlander A, et al
    Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2016 Jan 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  221. RIZZI MA, Alquezar A, Marcuello JM, Ontiveros HH, et al
    The Redin SCORE: useful, but not for all.
    Eur J Heart Fail. 2016;18:116.
    PubMed     Text format    


  222. ALVAREZ-GARCIA J, Ferrero-Gregori A, Puig T, Cinca J, et al
    The Redin SCORE: useful, but not for all: reply.
    Eur J Heart Fail. 2016;18:117.
    PubMed     Text format    


  223. BRAMLAGE P, Swift SL, Thoenes M, Minguet J, et al
    Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease.
    Eur J Heart Fail. 2016;18:28-37.
    PubMed     Text format     Abstract available


    December 2015
  224. TER MAATEN JM, Voors AA
    Renal dysfunction in heart failure with a preserved ejection fraction: cause or consequence?
    Eur J Heart Fail. 2015 Dec 28. doi: 10.1002.
    PubMed     Text format    


  225. SAMSKY MD, Dunning A, DeVore AD, Schulte PJ, et al
    Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.
    Eur J Heart Fail. 2015 Dec 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  226. DAMMAN K, Kjekshus J, Wikstrand J, Cleland JG, et al
    Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
    Eur J Heart Fail. 2015 Dec 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  227. BHANDARI SS, Narayan H, Jones DJ, Suzuki T, et al
    Plasma growth hormone is a strong predictor of risk at 1 year in acute heart failure.
    Eur J Heart Fail. 2015 Dec 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  228. HAWKINS NM, Virani SA, Sperrin M, Buchan IE, et al
    Predicting heart failure decompensation using cardiac implantable electronic devices: a review of practices and challenges.
    Eur J Heart Fail. 2015 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  229. PEREZ AL, Grodin JL, Wu Y, Hernandez AF, et al
    Increased mortality with elevated plasma endothelin-1 in acute heart failure: an ASCEND-HF biomarker substudy.
    Eur J Heart Fail. 2015 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  230. BARTUNEK J, Davison B, Sherman W, Povsic T, et al
    Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial design.
    Eur J Heart Fail. 2015 Dec 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  231. ELDER DH, Singh JS, Levin D, Donnelly LA, et al
    Mean HbA and mortality in diabetic individuals with heart failure: a population cohort study.
    Eur J Heart Fail. 2015 Dec 13. doi: 10.1002.
    PubMed     Text format     Abstract available


  232. UNGER ED, Dubin RF, Deo R, Daruwalla V, et al
    Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  233. DEMISSEI BG, Cleland JG, O'Connor CM, Metra M, et al
    Optimizing clinical use of biomarkers in high-risk acute heart failure patients.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  234. VADUGANATHAN M, Michel A, Hall K, Mulligan C, et al
    Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  235. PITT B, Weir MR
    Response to: Hyperkalaemia in heart failure: binding the patient to improved treatment?
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format    


  236. SPERANDEO M, Di Stolfo G, Carnevale V
    'B line' in heart failure: a not so easy issue.
    Eur J Heart Fail. 2015 Dec 3. doi: 10.1002.
    PubMed     Text format    



  237. Corrigendum to 'Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart' [Eur J Heart Fail] 2015 August;17(8): 760-763. doi:10.1002/ejhf.315.
    Eur J Heart Fail. 2015;17:1317.
    PubMed     Text format    


  238. VAN DER WAL HH, Cowie MR, van der Meer P
    Sleep-disordered breathing and chronic heart failure: changing position may be important.
    Eur J Heart Fail. 2015;17:1219-22.
    PubMed     Text format    


  239. VESCOVO G
    Neuromuscular junction fragmentation and muscle wasting in heart failure: a sharp cut from a Sica sword?
    Eur J Heart Fail. 2015;17:1216-8.
    PubMed     Text format    


    November 2015
  240. MANN DL, Lee RJ, Coats AJ, Neagoe G, et al
    One-year follow-up results from AUGMENT-HF: a multicentre randomized controlled clinical trial of the efficacy of left ventricular augmentation with Algisyl in the treatment of heart failure.
    Eur J Heart Fail. 2015 Nov 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  241. LYON AR, Bossone E, Schneider B, Sechtem U, et al
    Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2015 Nov 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  242. RICHARDS AM, Frampton CM
    Can circulating biomarkers identify heart failure patients at low risk?
    Eur J Heart Fail. 2015 Nov 4. doi: 10.1002.
    PubMed     Text format    


  243. VOLPE M, Santolamazza C, Mastromarino V
    Erythropoiesis-stimulating agents in heart failure: leave it or re-take it?
    Eur J Heart Fail. 2015 Nov 3. doi: 10.1002.
    PubMed     Text format    


    October 2015
  244. STORK S, Kavoliuniene A, Vinereanu D, Ludwig R, et al
    What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative.
    Eur J Heart Fail. 2015 Oct 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  245. EMMENS JE, Ter Maaten JM, Matsue Y, Metra M, et al
    Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.
    Eur J Heart Fail. 2015 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  246. SAHLE BW, Owen AJ, Krum H, Reid CM, et al
    Incidence of heart failure in 6083 elderly hypertensive patients: the Second Australian National Blood Pressure Study (ANBP2).
    Eur J Heart Fail. 2015 Oct 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  247. DESTA L, Jernberg T, Spaak J, Hofman-Bang C, et al
    Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91 360 patients admitted with index myocardial infarction between 1998 and 2010.
    Eur J Heart Fail. 2015 Oct 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  248. CHAN MM, Santhanakrishnan R, Chong JP, Chen Z, et al
    Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Eur J Heart Fail. 2015 Oct 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  249. D'ELIA E, Vaduganathan M, Gori M, Gavazzi A, et al
    Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.
    Eur J Heart Fail. 2015 Oct 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  250. SANDERS-VAN WIJK S, van Empel V, Davarzani N, Maeder MT, et al
    Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
    Eur J Heart Fail. 2015 Oct 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  251. GARGANI L
    Prognosis in heart failure: look at the lungs.
    Eur J Heart Fail. 2015 Oct 16. doi: 10.1002.
    PubMed     Text format    


  252. FERRE RM, Chioncel O, Pang PS, Lang RM, et al
    Acute heart failure: the role of focused emergency cardiopulmonary ultrasound in identification and early management.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format    


  253. AMBROSY AP, Hernandez AF, Armstrong PW, Butler J, et al
    The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  254. MELENOVSKY V, Andersen MJ, Andress K, Reddy YN, et al
    Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  255. PINNA GD, Robbi E, La Rovere MT, Taurino AE, et al
    Differential impact of body position on the severity of disordered breathing in heart failure patients with obstructive vs. central sleep apnoea.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  256. PARISSIS J, Farmakis D, Karavidas A, Arapi S, et al
    Functional electrical stimulation of lower limb muscles as an alternative mode of exercise training in chronic heart failure: practical considerations and proposed algorithm.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format    


  257. MEIJERS WC, de Boer RA, van Veldhuisen DJ, Jaarsma T, et al
    Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH.
    Eur J Heart Fail. 2015 Oct 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  258. PITT B, Bakris GL, Bushinsky DA, Garza D, et al
    Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors.
    Eur J Heart Fail. 2015 Oct 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  259. ASCHAUER S, Kammerlander AA, Zotter-Tufaro C, Ristl R, et al
    The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics.
    Eur J Heart Fail. 2015 Oct 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  260. STEINBECK L, Ebner N, Valentova M, Bekfani T, et al
    Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
    Eur J Heart Fail. 2015 Oct 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  261. KONSTAM MA
    Hyperkalaemia in heart failure: binding the patient to improved treatment?
    Eur J Heart Fail. 2015 Oct 7. doi: 10.1002.
    PubMed     Text format    


  262. VON LUEDER TG, Girerd N, Atar D, Agewall S, et al
    Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.
    Eur J Heart Fail. 2015 Oct 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  263. WAGENAAR KP, Broekhuizen BD, Dickstein K, Jaarsma T, et al
    Effectiveness of an interactive platform, and the ESC/HFA heartfailurematters.org website in patients with heart failure: design of the multicentre randomized e-Vita heart failure trial.
    Eur J Heart Fail. 2015 Oct 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  264. BELLO NA, Lewis EF, Desai AS, Anand IS, et al
    Increased risk of stroke with darbepoetin alfa in anaemic heart failure patients with diabetes and chronic kidney disease.
    Eur J Heart Fail. 2015 Oct 1. doi: 10.1002.
    PubMed     Text format     Abstract available


  265. KRUM H, McMurray JJ, Abraham WT, Dickstein K, et al
    The Aliskiren Trial to Minimize OutcomeS in Patients with HEart failure trial (ATMOSPHERE): revised statistical analysis plan and baseline characteristics.
    Eur J Heart Fail. 2015;17:1075-83.
    PubMed     Text format     Abstract available


  266. ANSELMINO M, Matta M, Gaita F
    Catheter ablation of atrial fibrillation in patients with heart failure: can we break the vicious circle?
    Eur J Heart Fail. 2015;17:1003-5.
    PubMed     Text format    


    September 2015
  267. BRUNNER-LA ROCCA HP, Eurlings L, Richards AM, Januzzi JL, et al
    Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
    Eur J Heart Fail. 2015 Sep 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  268. TEIXEIRA A, Parenica J, Park JJ, Ishihara S, et al
    Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort.
    Eur J Heart Fail. 2015 Sep 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  269. COIRO S, Rossignol P, Ambrosio G, Carluccio E, et al
    Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure.
    Eur J Heart Fail. 2015 Sep 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  270. BANG C, Antoniades C, Antonopoulos AS, Eriksson U, et al
    Intercellular communication lessons in heart failure.
    Eur J Heart Fail. 2015 Sep 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  271. BRAUNWALD E
    Another step toward personalized care of patients with heart failure.
    Eur J Heart Fail. 2015 Sep 16. doi: 10.1002.
    PubMed     Text format    


  272. KOMAJDA M, Tavazzi L, Francq BG, Bohm M, et al
    Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial.
    Eur J Heart Fail. 2015 Sep 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  273. GREENE SJ, Fonarow GC
    Insulin resistance in heart failure: widening the divide between reduced and preserved ejection fraction?
    Eur J Heart Fail. 2015 Sep 16. doi: 10.1002.
    PubMed     Text format    


  274. SIMPSON J, Castagno D, Doughty RN, Poppe KK, et al
    Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis.
    Eur J Heart Fail. 2015 Sep 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  275. OVCHINNIKOVA ES, Schmitter D, Vegter EL, Ter Maaten JM, et al
    Signature of circulating microRNAs in patients with acute heart failure.
    Eur J Heart Fail. 2015 Sep 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  276. XIONG Q, Lau YC, Senoo K, Lane DA, et al
    Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials.
    Eur J Heart Fail. 2015 Sep 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  277. MICHAEL FELKER G, Mentz RJ, Teerlink JR, Voors AA, et al
    Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study.
    Eur J Heart Fail. 2015 Sep 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  278. COTTER G, Voors AA, Prescott MF, Felker GM, et al
    Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study.
    Eur J Heart Fail. 2015 Sep 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  279. FELKER GM, Ahmad T
    Reclassifying heart failure: time for disruptive innovation?
    Eur J Heart Fail. 2015 Sep 2. doi: 10.1002.
    PubMed     Text format    


    August 2015
  280. LIP GY, Heinzel FR, Gaita F, Juanatey JR, et al
    European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.
    Eur J Heart Fail. 2015 Aug 21. doi: 10.1002.
    PubMed     Text format    


  281. PELLICORI P, Clark AL
    Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure.
    Eur J Heart Fail. 2015 Aug 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  282. GREENE SJ, Gheorghiade M
    Same protocol, different continents, different patients: should we continue to conduct global heart failure trials?
    Eur J Heart Fail. 2015 Aug 20. doi: 10.1002.
    PubMed     Text format    


  283. KAO DP, Lewsey JD, Anand IS, Massie BM, et al
    Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
    Eur J Heart Fail. 2015 Aug 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  284. BUTLER J, Gheorghiade M, Kelkar A, Fonarow GC, et al
    In-hospital worsening heart failure.
    Eur J Heart Fail. 2015 Aug 3. doi: 10.1002.
    PubMed     Text format     Abstract available


    July 2015
  285. PLATZ E, Jhund PS, Campbell RT, McMurray JJ, et al
    Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review.
    Eur J Heart Fail. 2015 Jul 31. doi: 10.1002.
    PubMed     Text format     Abstract available


  286. STIENEN S, Salah K, Eurlings LW, Bettencourt P, et al
    Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro a brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
    Eur J Heart Fail. 2015 Jul 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  287. SHIMOKAWA H, Miura M, Nochioka K, Sakata Y, et al
    Heart failure as a general pandemic in Asia.
    Eur J Heart Fail. 2015 Jul 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  288. VAGNARELLI F, Corsini A, Lorenzini M, Pacini D, et al
    Acute heart failure in patients with acute aortic syndrome: pathophysiology and clinical-prognostic implications.
    Eur J Heart Fail. 2015 Jul 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  289. VERBRUGGE FH, Dupont M, Finucan M, Gabi A, et al
    Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure.
    Eur J Heart Fail. 2015 Jul 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  290. FERREIRA JP, Girerd N, Rossignol P, Zannad F, et al
    Geographic differences in heart failure trials.
    Eur J Heart Fail. 2015 Jul 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  291. SCHERBAKOV N, Bauer M, Sandek A, Szabo T, et al
    Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
    Eur J Heart Fail. 2015 Jul 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  292. LATINI R, Masson S
    Understanding and making good use of changes in natriuretic peptide levels in chronic heart failure.
    Eur J Heart Fail. 2015 Jul 15. doi: 10.1002.
    PubMed     Text format    


  293. SENNI M, Gavazzi A, Gheorghiade M, Butler J, et al
    Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart.
    Eur J Heart Fail. 2015 Jul 15. doi: 10.1002.
    PubMed     Text format    


  294. WOLSK E, Lamberts M, Hansen ML, Blanche P, et al
    Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study.
    Eur J Heart Fail. 2015 Jul 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  295. JAARSMA T, Klompstra L, Ben Gal T, Boyne J, et al
    Increasing exercise capacity and quality of life of patients with heart failure through Wii gaming: the rationale, design and methodology of the HF-Wii study; a multicentre randomized controlled trial.
    Eur J Heart Fail. 2015;17:743-8.
    PubMed     Text format     Abstract available


  296. CANNON JA, Collier TJ, Shen L, Swedberg K, et al
    Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).
    Eur J Heart Fail. 2015;17:707-16.
    PubMed     Text format     Abstract available


  297. LEDWIDGE MT, O'Connell E, Gallagher J, Tilson L, et al
    Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study.
    Eur J Heart Fail. 2015;17:672-9.
    PubMed     Text format     Abstract available


  298. HOTHI SS, Tan LB, Cotter G
    Resting cardiac power index and prediction of prognosis in heart failure.
    Eur J Heart Fail. 2015;17:642-4.
    PubMed     Text format    


    June 2015
  299. MONTERO-PEREZ-BARQUERO M, Formiga F, Manzano L
    About the RICA registry in patients with heart failure.
    Eur J Heart Fail. 2015 Jun 24. doi: 10.1002.
    PubMed     Text format    


  300. HAUPTMAN PJ
    Addressing disparities in heart failure care without borders.
    Eur J Heart Fail. 2015 Jun 17. doi: 10.1002.
    PubMed     Text format    


  301. MENTZ RJ, Metra M, Cotter G, Milo O, et al
    Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial.
    Eur J Heart Fail. 2015 Jun 17. doi: 10.1002.
    PubMed     Text format     Abstract available


  302. FERRARI R, Bohm M, Cleland JG, Paulus WJ, et al
    Heart failure with preserved ejection fraction: uncertainties and dilemmas.
    Eur J Heart Fail. 2015 Jun 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  303. PARISSIS J, Farmakis D, Lekakis J, Filippatos G, et al
    Overcoming the ethnic differences in patients hospitalized for heart failure: is there a need for international harmonization of clinical practice guidelines?
    Eur J Heart Fail. 2015 Jun 4. doi: 10.1002.
    PubMed     Text format    


  304. MEBAZAA A, Longrois D, Metra M, Mueller C, et al
    Agents with vasodilator properties in acute heart failure: how to design successful trials.
    Eur J Heart Fail. 2015 Jun 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  305. PARK JJ, Choi DJ, Yoon CH, Oh IY, et al
    The prognostic value of arterial blood gas analysis in high-risk acute heart failure patients: an analysis of the Korean Heart Failure (KorHF) registry.
    Eur J Heart Fail. 2015;17:601-11.
    PubMed     Text format     Abstract available


  306. GRIGIONI F, Senni M
    The Pilot European Survey of Atrial Fibrillation: how to look at heart failure through a keyhole.
    Eur J Heart Fail. 2015;17:541-3.
    PubMed     Text format    


  307. KARPER JC, Westenbrink BD
    BNP in heart failure: even leucocytes cannot escape its influence.
    Eur J Heart Fail. 2015;17:536-8.
    PubMed     Text format    


    May 2015
  308. DONAL E, Lund LH, Oger E, Hage C, et al
    New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
    Eur J Heart Fail. 2015 May 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  309. DI TANO G, De Maria R, Gonzini L, Aspromonte N, et al
    The 30-day metric in acute heart failure revisited: data from IN-HF Outcome, an Italian nationwide cardiology registry.
    Eur J Heart Fail. 2015 May 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  310. MACDONALD MR, She L, Doenst T, Binkley PF, et al
    Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
    Eur J Heart Fail. 2015 May 26. doi: 10.1002.
    PubMed     Text format     Abstract available


  311. ZILE MR, Abraham WT, Weaver FA, Butter C, et al
    Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Cardiac Resynchronization Therapy.
    Eur J Heart Fail. 2015 May 25. doi: 10.1002.
    PubMed     Text format     Abstract available


  312. ANKER SD, Kosiborod M, Zannad F, Pina IL, et al
    Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.
    Eur J Heart Fail. 2015 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  313. ALVAREZ-GARCIA J, Ferrero-Gregori A, Puig T, Vazquez R, et al
    A simple validated method for predicting the risk of hospitalization for worsening of heart failure in ambulatory patients: the Redin-SCORE.
    Eur J Heart Fail. 2015 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  314. HARIKRISHNAN S, Sanjay G, Anees T, Viswanathan S, et al
    Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry.
    Eur J Heart Fail. 2015 May 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  315. MEBAZAA A, Birhan Yilmaz M, Levy P, Ponikowski P, et al
    Recommendations on pre-hospital & hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emerge
    Eur J Heart Fail. 2015 May 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  316. GOTSMAN I, Avishai-Eliner S, Jabara R, Zemora Z, et al
    Ethnic disparity in the clinical characteristics of patients with heart failure.
    Eur J Heart Fail. 2015 May 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  317. KHAN H, Greene SJ, Fonarow GC, Kalogeropoulos AP, et al
    Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.
    Eur J Heart Fail. 2015 May 9. doi: 10.1002.
    PubMed     Text format     Abstract available


  318. GABET A, Juilliere Y, Lamarche-Vadel A, Vernay M, et al
    National trends in rate of patients hospitalized for heart failure and heart failure mortality in France, 2000-2012.
    Eur J Heart Fail. 2015 May 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  319. RUGGENENTI P, Remuzzi G
    Combined neprilysin and RAS inhibition for the failing heart: straining the kidney to help the heart?
    Eur J Heart Fail. 2015;17:468-71.
    PubMed     Text format    


  320. METRA M
    May 2015 at a glance.
    Eur J Heart Fail. 2015;17:465.
    PubMed     Text format    


  321. HARJOLA VP, Lassus J, Sionis A, Kober L, et al
    Clinical picture and risk prediction of short-term mortality in cardiogenic shock.
    Eur J Heart Fail. 2015;17:501-9.
    PubMed     Text format     Abstract available


    April 2015
  322. GREENE SJ, Fonarow GC, Solomon SD, Subacius H, et al
    Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial.
    Eur J Heart Fail. 2015 Apr 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  323. HERSCOVICI R, Kutyifa V, Barsheshet A, Solomon S, et al
    Early intervention and long-term outcome with cardiac resynchronization therapy in patients without a history of advanced heart failure symptoms.
    Eur J Heart Fail. 2015 Apr 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  324. JHUND PS, Anand IS, Komajda M, Claggett BL, et al
    Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
    Eur J Heart Fail. 2015 Apr 29. doi: 10.1002.
    PubMed     Text format     Abstract available


  325. FESTEN S, de Rooij SE
    Heart failure and brain failure: two of a kind?
    Eur J Heart Fail. 2015 Apr 28. doi: 10.1002.
    PubMed     Text format    


  326. GRODIN JL, Mullens W, Dupont M, Wu Y, et al
    Prognostic role of cardiac power index in ambulatory patients with advanced heart failure.
    Eur J Heart Fail. 2015 Apr 28. doi: 10.1002.
    PubMed     Text format     Abstract available


  327. ZANNAD F, Greenberg B, Cleland JG, Gheorghiade M, et al
    Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and s
    Eur J Heart Fail. 2015 Apr 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  328. PIEPOLI MF, Binno S, Corra U, Seferovic P, et al
    ExtraHF survey: the first European survey on implementation of exercise training in heart failure patients.
    Eur J Heart Fail. 2015 Apr 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  329. STEWART S, Chan YK, Wong C, Jennings G, et al
    Impact of a nurse-led home and clinic-based secondary prevention programme to prevent progressive cardiac dysfunction in high-risk individuals: the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) randomized controlled study.
    Eur J Heart Fail. 2015 Apr 21. doi: 10.1002.
    PubMed     Text format     Abstract available


  330. DE BOER RA, Daniels LB, Maisel AS, Januzzi JL Jr, et al
    State of the Art: Newer biomarkers in heart failure.
    Eur J Heart Fail. 2015 Apr 16. doi: 10.1002.
    PubMed     Text format     Abstract available


  331. KADOTA S, Carey J, Reinecke H, Leggett J, et al
    Ribonucleotide reductase-mediated increase in dATP improves cardiac performance via myosin activation in a large animal model of heart failure.
    Eur J Heart Fail. 2015 Apr 15. doi: 10.1002.
    PubMed     Text format     Abstract available


  332. GREENE SJ, Fonarow GC, Butler J
    REPORT-HF: the unique blend of global heart failure registry and longitudinal cohort study.
    Eur J Heart Fail. 2015 Apr 8. doi: 10.1002.
    PubMed     Text format    


  333. SCHMITTER D, Voors AA, van der Harst P
    HFpEF vs. HFrEF: can microRNAs advance the diagnosis?
    Eur J Heart Fail. 2015;17:351-4.
    PubMed     Text format    


  334. METRA M
    April 2015 at a glance.
    Eur J Heart Fail. 2015;17:347.
    PubMed     Text format    


    March 2015
  335. BOHM M, Borer JS, Camm J, Ford I, et al
    Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy.
    Eur J Heart Fail. 2015 Mar 20. doi: 10.1002.
    PubMed     Text format     Abstract available


  336. FILIPPATOS G, Khan SS, Ambrosy AP, Cleland JG, et al
    International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry.
    Eur J Heart Fail. 2015 Mar 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  337. SULAIMAN K, Panduranga P, Al-Zakwani I, Alsheikh-Ali AA, et al
    Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf acute heart failure registry (Gulf CARE).
    Eur J Heart Fail. 2015 Mar 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  338. WATSON CJ, Gupta SK, O'Connell E, Thum S, et al
    MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure.
    Eur J Heart Fail. 2015 Mar 4. doi: 10.1002.
    PubMed     Text format     Abstract available


  339. LIP GY, Laroche C, Popescu MI, Rasmussen LH, et al
    Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation.
    Eur J Heart Fail. 2015 Mar 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  340. GUDER G, Stork S, Gelbrich G, Brenner S, et al
    Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Eur J Heart Fail. 2015 Mar 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  341. MCMURRAY JJ
    Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances.
    Eur J Heart Fail. 2015;17:242-7.
    PubMed     Text format     Abstract available


  342. MAASS AH, Westenbrink BD
    Cardiac resynchronization therapy in mild heart failure should be reserved for true dyssynchronopathy.
    Eur J Heart Fail. 2015;17:239-41.
    PubMed     Text format    


  343. PONIKOWSKI P, Filippatos G, Colet JC, Willenheimer R, et al
    The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study.
    Eur J Heart Fail. 2015;17:329-39.
    PubMed     Text format     Abstract available


  344. LAM CS, McEntegart M, Claggett B, Liu J, et al
    Sex differences in clinical characteristics and outcomes after myocardial infarction: insights from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    Eur J Heart Fail. 2015;17:301-12.
    PubMed     Text format     Abstract available


    February 2015
  345. ANDERSEN S, Andersen A, de Man FS, Nielsen-Kudsk JE, et al
    Sympathetic nervous system activation and beta-adrenoceptor blockade in right heart failure.
    Eur J Heart Fail. 2015 Feb 22. doi: 10.1002.
    PubMed     Text format     Abstract available


  346. WOO MA, Ogren JA, Abouzeid CM, Macey PM, et al
    Regional hippocampal damage in heart failure.
    Eur J Heart Fail. 2015 Feb 22. doi: 10.1002.
    PubMed     Text format     Abstract available


  347. ROSSIGNOL P, Masson S, Barlera S, Girerd N, et al
    Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials.
    Eur J Heart Fail. 2015 Feb 22. doi: 10.1002.
    PubMed     Text format     Abstract available


  348. KLATSKY AL
    Alcohol drinking and heart failure: where do we stand?
    Eur J Heart Fail. 2015 Feb 17. doi: 10.1002.
    PubMed     Text format    


  349. FEINSTEIN MJ, Jhund P, Kang J, Ning H, et al
    Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.
    Eur J Heart Fail. 2015 Feb 14. doi: 10.1002.
    PubMed     Text format     Abstract available


  350. DICKSTEIN K
    Increased pulmonary vascular resistance, right ventricular dysfunction, and reversible pulmonary vasoconstriction in type 2 pulmonary hypertension: who has it and are we missing a potential therapeutic target in patients with heart failure?
    Eur J Heart Fail. 2015 Feb 11. doi: 10.1002.
    PubMed     Text format    


  351. LOPEZ B, Gonzalez A, Querejeta R, Zubillaga E, et al
    Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
    Eur J Heart Fail. 2015 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  352. LIU S, Ngo DT, Chong CR, Amarasekera AT, et al
    Suppression of neutrophil superoxide generation by BNP is attenuated in acute heart failure: a case for 'BNP resistance'
    Eur J Heart Fail. 2015 Feb 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  353. VOORS AA, Gori M, Liu LC, Claggett B, et al
    Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction.
    Eur J Heart Fail. 2015 Feb 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  354. SCOTT BOWEN T, Rolim NP, Fischer T, Baekkerud FH, et al
    Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle.
    Eur J Heart Fail. 2015 Feb 6. doi: 10.1002.
    PubMed     Text format     Abstract available


  355. HAVER VG, Mateo Leach I, Kjekshus J, Fox JC, et al
    Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).
    Eur J Heart Fail. 2015 Feb 2. doi: 10.1002.
    PubMed     Text format     Abstract available


  356. CHEN A, Chen YM
    Donepezil, a potential therapeutic agent for heart failure.
    Eur J Heart Fail. 2015;17:233.
    PubMed     Text format    


  357. PITT B, Anker SD, Bohm M, Gheorghiade M, et al
    Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.
    Eur J Heart Fail. 2015;17:224-232.
    PubMed     Text format     Abstract available


  358. BADAR AA, Perez-Moreno AC, Hawkins NM, Brunton AP, et al
    Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme.
    Eur J Heart Fail. 2015;17:196-204.
    PubMed     Text format     Abstract available


  359. GOLD MR, van Veldhuisen DJ, Mann DL
    Vagal nerve stimulation for heart failure: new pieces to the puzzle?
    Eur J Heart Fail. 2015;17:125-127.
    PubMed     Text format    


  360. METRA M
    The European Journal of Heart Failure now and in the years to come: a salutation from the incoming Editor-in-Chief.
    Eur J Heart Fail. 2015;17:119-121.
    PubMed     Text format    


  361. KRISTENSEN SL, Jhund PS, Kober L, Preiss D, et al
    Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction.
    Eur J Heart Fail. 2015;17:169-76.
    PubMed     Text format     Abstract available


  362. BRUNNER-LA ROCCA HP, Knackstedt C, Eurlings L, Rolny V, et al
    Impact of worsening renal function related to medication in heart failure.
    Eur J Heart Fail. 2015;17:159-68.
    PubMed     Text format     Abstract available


  363. MILLER WL, Borgeson DD, Grantham JA, Luchner A, et al
    Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failure.
    Eur J Heart Fail. 2015;17:144-50.
    PubMed     Text format     Abstract available


    January 2015
  364. MCDONAGH T, Macdougall IC
    Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
    Eur J Heart Fail. 2015 Jan 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  365. DEVORE AD, Hasselblad V, Mentz RJ, O'Connor CM, et al
    Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    Eur J Heart Fail. 2015 Jan 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  366. WONG LL, Armugam A, Sepramaniam S, Karolina DS, et al
    Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction.
    Eur J Heart Fail. 2015 Jan 23. doi: 10.1002.
    PubMed     Text format     Abstract available


  367. LARSSON SC, Orsini N, Wolk A
    Alcohol consumption and risk of heart failure: a dose-response meta-analysis of prospective studies.
    Eur J Heart Fail. 2015 Jan 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  368. SCHMID JP, Nobel D, Brugger N, Novak J, et al
    Short-term high altitude exposure at 3454 m is well tolerated in patients with stable heart failure.
    Eur J Heart Fail. 2015 Jan 19. doi: 10.1002.
    PubMed     Text format     Abstract available


  369. MICHEL A, Martin-Perez M, Ruigomez A, Garcia Rodriguez LA, et al
    Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case-control study in UK general practice.
    Eur J Heart Fail. 2015 Jan 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  370. CERMAKOVA P, Lund LH, Fereshtehnejad SM, Johnell K, et al
    Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders.
    Eur J Heart Fail. 2015 Jan 10. doi: 10.1002.
    PubMed     Text format     Abstract available


  371. FRANSSEN C, Paulus WJ
    Normal resting pulmonary artery wedge pressure: a diagnostic trap for heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2015 Jan 2. doi: 10.1002.
    PubMed     Text format    


  372. GREENE SJ, Maggioni AP, Fonarow GC, Solomon SD, et al
    Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.
    Eur J Heart Fail. 2015;17:98-108.
    PubMed     Text format     Abstract available


  373. PANI L, Pecorelli S, Rosano G, Anker SD, et al
    Steps forward in regulatory pathways for acute and chronic heart failure.
    Eur J Heart Fail. 2015;17:3-8.
    PubMed     Text format     Abstract available


  374. JOYCE E, Ninaber MK, Katsanos S, Debonnaire P, et al
    Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis.
    Eur J Heart Fail. 2015;17:51-62.
    PubMed     Text format     Abstract available


    December 2014
  375. DAVISON B, Cotter G
    Why is heart failure so important in the 21st century?
    Eur J Heart Fail. 2014 Dec 30. doi: 10.1002.
    PubMed     Text format    


  376. BOONMAN-DE WINTER LJ, Rutten FH, Cramer MJ, Landman MJ, et al
    Efficiently screening heart failure in patients with type 2 diabetes.
    Eur J Heart Fail. 2014 Dec 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  377. VERBRUGGE FH, Dupont M, Bertrand PB, Nijst P, et al
    Pulmonary vascular response to exercise in symptomatic heart failure with reduced ejection fraction and pulmonary hypertension.
    Eur J Heart Fail. 2014 Dec 30. doi: 10.1002.
    PubMed     Text format     Abstract available


  378. MAOR E, Grossman Y, Balmor RG, Segel M, et al
    Exercise haemodynamics may unmask the diagnosis of diastolic dysfunction among patients with pulmonary hypertension.
    Eur J Heart Fail. 2014 Dec 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  379. HAI OY, Mentz RJ, Zannad F, Gasparini M, et al
    Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction.
    Eur J Heart Fail. 2014 Dec 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  380. LING HZ, Flint J, Damgaard M, Bonfils PK, et al
    Calculated plasma volume status and prognosis in chronic heart failure.
    Eur J Heart Fail. 2014 Dec 3. doi: 10.1002.
    PubMed     Text format     Abstract available


  381. SHOAIB A, Waleed M, Khan S, Raza A, et al
    Breathlessness at rest is not the dominant presentation of patients admitted with heart failure.
    Eur J Heart Fail. 2014;16:1283-91.
    PubMed     Text format     Abstract available


  382. CAMPBELL RT, McKean AR, McMurray JJ
    Acute heart failure: have we got it all wrong?
    Eur J Heart Fail. 2014;16:1263-7.
    PubMed     Text format    


  383. VAN VELDHUISEN DJ
    The European Journal of Heart Failure from 2010 to 2015: A farewell and a move of the Editorial Team from Groningen to Brescia.
    Eur J Heart Fail. 2014;16:1259-62.
    PubMed     Text format    


  384. CHENG S, McCabe EL, Larson MG, Chen MH, et al
    Left ventricular mechanical function: clinical correlates, heritability, and association with parental heart failure.
    Eur J Heart Fail. 2014 Dec 1. doi: 10.1002.
    PubMed     Text format     Abstract available


    November 2014
  385. METRA M, Mentz RJ, Chiswell K, Bloomfield DM, et al
    Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial.
    Eur J Heart Fail. 2014 Nov 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  386. GOUDIE A, Elder D, Deshmukh H, Szwejkowski BR, et al
    Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study.
    Eur J Heart Fail. 2014 Nov 27. doi: 10.1002.
    PubMed     Text format     Abstract available


  387. EDELMANN F, Holzendorf V, Wachter R, Nolte K, et al
    Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial.
    Eur J Heart Fail. 2014 Nov 24. doi: 10.1002.
    PubMed     Text format     Abstract available


  388. ERDEI T, Smiseth OA, Marino P, Fraser AG, et al
    A systematic review of diastolic stress tests in heart failure with preserved ejection fraction, with proposals from the EU-FP7 MEDIA study group.
    Eur J Heart Fail. 2014 Nov 12. doi: 10.1002.
    PubMed     Text format     Abstract available


  389. KUHL U, Lassner D, Wallaschek N, Gross UM, et al
    Chromosomally integrated human herpesvirus 6 in heart failure: prevalence and treatment.
    Eur J Heart Fail. 2014 Nov 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  390. DRAGU R, Rispler S, Habib M, Sholy H, et al
    Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension.
    Eur J Heart Fail. 2014 Nov 11. doi: 10.1002.
    PubMed     Text format     Abstract available


  391. RAUTIAINEN S, Levitan EB, Mittleman MA, Wolk A, et al
    Fruit and vegetable intake and rate of heart failure: a population-based prospective cohort of women.
    Eur J Heart Fail. 2014 Nov 8. doi: 10.1002.
    PubMed     Text format     Abstract available


  392. KUTYIFA V, Geller L, Bogyi P, Zima E, et al
    Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
    Eur J Heart Fail. 2014 Nov 7. doi: 10.1002.
    PubMed     Text format     Abstract available


  393. CHENG M, Lu X, Huang J, Zhang J, et al
    The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: insights from a meta-analysis.
    Eur J Heart Fail. 2014 Nov 5. doi: 10.1002.
    PubMed     Text format     Abstract available


  394. COTTER G, Metra M, Davison BA, Senger S, et al
    Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study.
    Eur J Heart Fail. 2014 Nov 5. doi: 10.1002.
    PubMed     Text format     Abstract available


    October 2014
  395. ANDERSSON C, Gislason GH, Hlatky MA, Sondergaard KB, et al
    A risk score for predicting 30-day mortality in heart failure patients undergoing non-cardiac surgery.
    Eur J Heart Fail. 2014 Oct 31. doi: 10.1002.
    PubMed     Text format     Abstract available


    September 2014
  396. YU CM, Fang F, Luo XX, Zhang Q, et al
    Long-term follow-up results of the pacing to avoid cardiac enlargement (PACE) trial.
    Eur J Heart Fail. 2014;16:1016-25.
    PubMed     Text format     Abstract available


    July 2014
  397. KHATIB M, Tolosana JM, Trucco E, Borras R, et al
    EAARN score, a predictive score for mortality in patients receiving cardiac resynchronization therapy based on pre-implantation risk factors.
    Eur J Heart Fail. 2014;16:802-9.
    PubMed     Text format     Abstract available


    June 2014
  398. KLIP IT, Jankowska EA, Enjuanes C, Voors AA, et al
    The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences.
    Eur J Heart Fail. 2014;16:655-62.
    PubMed     Text format     Abstract available


    May 2014
  399. BROUWERS C, de Jonge N, Caliskan K, Manintveld O, et al
    Predictors of changes in health status between and within patients 12 months post left ventricular assist device implantation.
    Eur J Heart Fail. 2014;16:566-73.
    PubMed     Text format     Abstract available


  400. HOLLANDER Z, Lazarova M, Lam KK, Ignaszewski A, et al
    Proteomic biomarkers of recovered heart function.
    Eur J Heart Fail. 2014;16:551-9.
    PubMed     Text format     Abstract available


    April 2014

  401. Abstracts of the 7th Asian Pacific Congress of Heart Failure, 17-19th April 2014, Bali, Indonesia.
    Eur J Heart Fail. 2014;16 Suppl 1:1-41.
    PubMed     Text format    


    March 2014
  402. MOUKARBEL GV, Yu ZF, Dickstein K, Hou YR, et al
    The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients.
    Eur J Heart Fail. 2014;16:289-99.
    PubMed     Text format     Abstract available


  403. DANDEL M, Knosalla C, Hetzer R
    Contribution of ventricular assist devices to the recovery of failing hearts: a review and the Berlin Heart Center Experience.
    Eur J Heart Fail. 2014;16:248-63.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: